-transparent.png){kind=logo}
Following our recent discovery that 9-beta-D-ribofuranosylpurine-6-carboxamide (1) exhibits potent antiviral activity, we were prompted to synthesize certain pyrrolopyrimidine and pyrazolopyrimidine nucleosides containing a carbamoyl function (7a,b and 13). The key precursor, 7-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine-4- carbonitrile (8a), required for the synthesis of 7a was prepared from the corresponding 4-chloro analogue (4a). Reaction of 4a with methanethiol, followed by oxidation, gave the 4-methylsulfonyl derivative (6a), which with NaCN in DMF gave 8a. Alkaline hydrolysis of 8a provided 7a. Similarly, 7b was prepared from 4-chloro-1-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)pyrazolo[3,4-d] pyrimidine (4b) via the carbonitrile intermediate 8b. Starting with thioformycin B or 7-chloro-3-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)pyrazolo[4,3-d]pyrimidine (10) and following the similar sequence of reactions, we obtained compound 13. The in vitro antiviral studies of these carbamoyl and certain related nucleosides indicated 7a to be a potent antiviral agent against vaccinia virus, whereas 13 was moderately active. 4-Chloro-7-beta-D-ribofuranosylpyrrolo[2,3-d]pyrimidine was found to be one of the most active compounds against RVF, PICH, YF, and SF viruses in culture.
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
February 1977,
Journal of medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
October 1981,
Journal of medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
June 2012,
Bioorganic & medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
November 2004,
Journal of medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
January 1971,
Journal of the Chemical Society. Perkin transactions 1,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
February 2003,
Current protocols in nucleic acid chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
January 1969,
Experientia,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
October 2000,
Journal of medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
April 1998,
Journal of medicinal chemistry,
R J Goebel, and
A D Adams, and
P A McKernan, and
B K Murray, and
R K Robins, and
G R Revankar, and
P G Canonico
January 2004,
Organic & biomolecular chemistry,
